Nasdaq
$0.6100▲ 0.89%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $238.8MShares out 3.900M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
25- 3d agoPre-market26.10.22 13:15filedEFFECTOther#●●●#●●●
STANDARD BIOTOOLS INC.
The registration statement (File No. 333-297560) filed by Standard BioTools Inc. was declared effective by the SEC on October 21, 2026. This effectiveness allows the company to proceed with the issuance of securities and associated capital raising activities as outlined in the filing.…more
$0.6100+0.89%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 3d agoAfter-hours26.10.22 05:30424B3Offering
STANDARD BIOTOOLS INC.
Standard BioTools has entered into an all-stock merger agreement with Treeline Biosciences, after which it will be renamed Treeline Biosciences and trade under the ticker 'TRLN' on Nasdaq. Upon completion, legacy Standard BioTools stockholders are expected to hold approximately 16% of the combined company, and the company will issue Contingent Value Rights (CVRs) to stockholders related to the divestiture of its legacy businesses. A special meeting of stockholders to vote on the merger and related proposals is scheduled for November 19, 2026.…more
$0.6100+0.89%vs prev closeView filingShare - 4d agoPre-market26.10.21 19:02S-4/AOffering
STANDARD BIOTOOLS INC.
Standard BioTools has filed an S-4/A registration statement for its merger with Treeline Biosciences. Upon completion, the company will be renamed Treeline Biosciences, and existing shareholders will receive Contingent Value Rights (CVRs) tied to proceeds from the divestiture of legacy businesses over five years. Post-merger, former Standard BioTools shareholders are expected to hold approximately 16% of the combined entity, with Treeline shareholders holding approximately 84%.…more
$0.6100+0.89%vs prev closeView filingShare
24 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 5d agoPre-market26.10.20 20:00Bullish#●●●#●●●
Labrador Gold Closes $2.1 Million First Tranche of Private Placement
Labrador Gold has closed the first tranche of its private placement, raising $2.1 million out of a total target of $7 million. The issuance of new shares may lead to shareholder dilution, warranting a cautious investment approach.…more
$0.6100+0.89%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 10.13Pre-market26.10.13 20:00
●●●●●●●● ●●●●● ●●●●●●
Labrador Gold has increased its non-brokered private placement from $4 million to $7 million due to strong investor demand. The proceeds will fund mineral exploration in Canada, though the significant issuance of new shares presents dilution risks for existing shareholders.…more
$0.6100+0.89%vs prev close - 10.5After-hours26.10.06 05:05
●●●●●●●● ●●●●● ●●●●●●
Standard BioTools has entered into a definitive agreement to sell its Microfluidics business to ARCHIMED. The transaction is part of the company's strategic restructuring and is expected to close in approximately 30 days.…more
$0.6100+0.89%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report